175 related articles for article (PubMed ID: 17611673)
1. Interleukin-1beta gene in esophageal, gastric and colorectal carcinomas.
Ito H; Kaneko K; Makino R; Konishi K; Kurahashi T; Yamamoto T; Katagiri A; Kumekawa Y; Kubota Y; Muramoto T; Mitamura K; Imawari M
Oncol Rep; 2007 Aug; 18(2):473-81. PubMed ID: 17611673
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma.
Figueiredo C; Machado JC; Pharoah P; Seruca R; Sousa S; Carvalho R; Capelinha AF; Quint W; Caldas C; van Doorn LJ; Carneiro F; Sobrinho-Simões M
J Natl Cancer Inst; 2002 Nov; 94(22):1680-7. PubMed ID: 12441323
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in interleukin-1B (IL-1B) and interleukin 1 receptor antagonist (IL-1RN) genes associate with gastric cancer risk in the Chinese population.
He BS; Pan YQ; Xu YF; Zhu C; Qu LL; Wang SK
Dig Dis Sci; 2011 Jul; 56(7):2017-23. PubMed ID: 21243433
[TBL] [Abstract][Full Text] [Related]
4. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease.
Chourasia D; Achyut BR; Tripathi S; Mittal B; Mittal RD; Ghoshal UC
Am J Gastroenterol; 2009 Nov; 104(11):2704-13. PubMed ID: 19603010
[TBL] [
